The topical study of inhaled drug (salbutamol) delivery in idiopathic pulmonary fibrosis
Respiratory Research Feb 14, 2018
Usmani OS, et al. - The total and regional lung delivery of salbutamol in subjects with idiopathic pulmonary fibrosis (IPF) were investigated herein. This first systematic investigation of inhaled drug delivery in fibrotic lung disease offered poof that inhaled drugs can be optimised to reach the peripheral areas of the lung where active scarring occurs in IPF.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries